Prefrontal Cortical GABAergic Dysfunction Contributes to Age-Related Working Memory Impairment

Working memory functions supported by the prefrontal cortex decline in normal aging. Disruption of corticolimbic GABAergic inhibitory circuits can impair working memory in young subjects; however, relatively little is known regarding how aging impacts prefrontal cortical GABAergic signaling and whet...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of neuroscience Vol. 34; no. 10; pp. 3457 - 3466
Main Authors Bañuelos, Cristina, Beas, B. Sofia, McQuail, Joseph A., Gilbert, Ryan J., Frazier, Charles J., Setlow, Barry, Bizon, Jennifer L.
Format Journal Article
LanguageEnglish
Published United States Society for Neuroscience 05.03.2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Working memory functions supported by the prefrontal cortex decline in normal aging. Disruption of corticolimbic GABAergic inhibitory circuits can impair working memory in young subjects; however, relatively little is known regarding how aging impacts prefrontal cortical GABAergic signaling and whether such changes contribute to cognitive deficits. The current study used a rat model to evaluate the effects of aging on expression of prefrontal GABAergic synaptic proteins in relation to working memory decline, and to test whether pharmacological manipulations of prefrontal GABAergic signaling can improve working memory abilities in aged subjects. Results indicate that in aged medial prefrontal cortex (mPFC), expression of the vesicular GABA transporter VGAT was unchanged; however, there was a significant increase in expression of the GABA synthesizing enzyme GAD67, and a significant decrease in the primary neuronal GABA transporter GAT-1 and in both subunits of the GABA(B) receptor (GABA(B)R). Expression of VGAT, GAD67, and GAT-1 was not associated with working memory ability. In contrast, among aged rats, GABA(B)R expression was significantly and negatively associated with working memory performance, such that lower GABA(B)R expression predicted better working memory. Subsequent experiments showed that systemic administration of a GABA(B)R antagonist, CGP55845, dose-dependently enhanced working memory in aged rats. This enhancing effect of systemic CGP55845 was reproduced by direct intra-mPFC administration. Together, these data suggest that age-related dysregulation of GABAergic signaling in prefrontal cortex may play a causal role in impaired working memory and that targeting GABA(B)Rs may provide therapeutic benefit for age-related impairments in executive functions.
AbstractList Working memory functions supported by the prefrontal cortex decline in normal aging. Disruption of corticolimbic GABAergic inhibitory circuits can impair working memory in young subjects; however, relatively little is known regarding how aging impacts prefrontal cortical GABAergic signaling and whether such changes contribute to cognitive deficits. The current study used a rat model to evaluate the effects of aging on expression of prefrontal GABAergic synaptic proteins in relation to working memory decline, and to test whether pharmacological manipulations of prefrontal GABAergic signaling can improve working memory abilities in aged subjects. Results indicate that in aged medial prefrontal cortex (mPFC), expression of the vesicular GABA transporter VGAT was unchanged; however, there was a significant increase in expression of the GABA synthesizing enzyme GAD67, and a significant decrease in the primary neuronal GABA transporter GAT-1 and in both subunits of the GABA(B) receptor (GABA(B)R). Expression of VGAT, GAD67, and GAT-1 was not associated with working memory ability. In contrast, among aged rats, GABA(B)R expression was significantly and negatively associated with working memory performance, such that lower GABA(B)R expression predicted better working memory. Subsequent experiments showed that systemic administration of a GABA(B)R antagonist, CGP55845, dose-dependently enhanced working memory in aged rats. This enhancing effect of systemic CGP55845 was reproduced by direct intra-mPFC administration. Together, these data suggest that age-related dysregulation of GABAergic signaling in prefrontal cortex may play a causal role in impaired working memory and that targeting GABA(B)Rs may provide therapeutic benefit for age-related impairments in executive functions.
Working memory functions supported by the prefrontal cortex decline in normal aging. Disruption of corticolimbic GABAergic inhibitory circuits can impair working memory in young subjects; however, relatively little is known regarding how aging impacts prefrontal cortical GABAergic signaling and whether such changes contribute to cognitive deficits. The current study used a rat model to evaluate the effects of aging on expression of prefrontal GABAergic synaptic proteins in relation to working memory decline, and to test whether pharmacological manipulations of prefrontal GABAergic signaling can improve working memory abilities in aged subjects. Results indicate that in aged medial prefrontal cortex (mPFC), expression of the vesicular GABA transporter VGAT was unchanged; however, there was a significant increase in expression of the GABA synthesizing enzyme GAD67, and a significant decrease in the primary neuronal GABA transporter GAT-1 and in both subunits of the GABA(B) receptor (GABA(B)R). Expression of VGAT, GAD67, and GAT-1 was not associated with working memory ability. In contrast, among aged rats, GABA(B)R expression was significantly and negatively associated with working memory performance, such that lower GABA(B)R expression predicted better working memory. Subsequent experiments showed that systemic administration of a GABA(B)R antagonist, CGP55845, dose-dependently enhanced working memory in aged rats. This enhancing effect of systemic CGP55845 was reproduced by direct intra-mPFC administration. Together, these data suggest that age-related dysregulation of GABAergic signaling in prefrontal cortex may play a causal role in impaired working memory and that targeting GABA(B)Rs may provide therapeutic benefit for age-related impairments in executive functions.Working memory functions supported by the prefrontal cortex decline in normal aging. Disruption of corticolimbic GABAergic inhibitory circuits can impair working memory in young subjects; however, relatively little is known regarding how aging impacts prefrontal cortical GABAergic signaling and whether such changes contribute to cognitive deficits. The current study used a rat model to evaluate the effects of aging on expression of prefrontal GABAergic synaptic proteins in relation to working memory decline, and to test whether pharmacological manipulations of prefrontal GABAergic signaling can improve working memory abilities in aged subjects. Results indicate that in aged medial prefrontal cortex (mPFC), expression of the vesicular GABA transporter VGAT was unchanged; however, there was a significant increase in expression of the GABA synthesizing enzyme GAD67, and a significant decrease in the primary neuronal GABA transporter GAT-1 and in both subunits of the GABA(B) receptor (GABA(B)R). Expression of VGAT, GAD67, and GAT-1 was not associated with working memory ability. In contrast, among aged rats, GABA(B)R expression was significantly and negatively associated with working memory performance, such that lower GABA(B)R expression predicted better working memory. Subsequent experiments showed that systemic administration of a GABA(B)R antagonist, CGP55845, dose-dependently enhanced working memory in aged rats. This enhancing effect of systemic CGP55845 was reproduced by direct intra-mPFC administration. Together, these data suggest that age-related dysregulation of GABAergic signaling in prefrontal cortex may play a causal role in impaired working memory and that targeting GABA(B)Rs may provide therapeutic benefit for age-related impairments in executive functions.
Author Gilbert, Ryan J.
McQuail, Joseph A.
Beas, B. Sofia
Bizon, Jennifer L.
Bañuelos, Cristina
Frazier, Charles J.
Setlow, Barry
Author_xml – sequence: 1
  givenname: Cristina
  surname: Bañuelos
  fullname: Bañuelos, Cristina
– sequence: 2
  givenname: B. Sofia
  surname: Beas
  fullname: Beas, B. Sofia
– sequence: 3
  givenname: Joseph A.
  surname: McQuail
  fullname: McQuail, Joseph A.
– sequence: 4
  givenname: Ryan J.
  surname: Gilbert
  fullname: Gilbert, Ryan J.
– sequence: 5
  givenname: Charles J.
  surname: Frazier
  fullname: Frazier, Charles J.
– sequence: 6
  givenname: Barry
  surname: Setlow
  fullname: Setlow, Barry
– sequence: 7
  givenname: Jennifer L.
  surname: Bizon
  fullname: Bizon, Jennifer L.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24599447$$D View this record in MEDLINE/PubMed
BookMark eNqFkV1vFCEYhYmpsdvWv9DMpTez8jksiTFZt7WuqW3T1ngnAYZZ0RlYgTHZfy-T1o160ytI3nPOe-A5Agc-eAvAKYJzxDB5_fHq_PPt9d1qPWdI4BqROYaIPgOzMhU1phAdgBnEHNYN5fQQHKX0HULIIeIvwCGmTAhK-Qx8vYm2i8Fn1VerELMz5XKxfLe0ceNMdbZL3ehNdsGXsc_R6THbVOVQLTe2vrW9yratvoT4w_lN9ckOIe6q9bBVLg7W5xPwvFN9si8fz2Nw__78fvWhvry-WK-Wl7UpLXLNDdam6wwhlFBGmoW2lnSigw3RxpAGtqhdWK2xFkgpaKDqNGkJZwvMFwiRY_D2IXY76sG2pmyOqpfb6AYVdzIoJ_-dePdNbsIvSQTFrOEl4NVjQAw_R5uyHFwytu-Vt2FMEpVFAnKBxdNSBhlmTDRTrdO_a-37_Pn-ImgeBCaGlAqJvQRBOXGWe85y4iwRkRPnYnzzn9G4rCZM5Xmuf8r-G5cLsRk
CitedBy_id crossref_primary_10_1523_ENEURO_0496_18_2019
crossref_primary_10_3233_JAD_191032
crossref_primary_10_1016_j_exger_2016_09_017
crossref_primary_10_1016_j_semcdb_2021_01_005
crossref_primary_10_3389_fnagi_2018_00391
crossref_primary_10_3758_s13415_022_01052_6
crossref_primary_10_1007_s11357_023_00993_1
crossref_primary_10_1016_j_dcn_2018_11_003
crossref_primary_10_1038_s41598_019_47555_0
crossref_primary_10_1007_s12035_019_01682_x
crossref_primary_10_1016_j_brs_2017_12_013
crossref_primary_10_1016_j_neuropsychologia_2017_06_028
crossref_primary_10_1038_s41398_017_0036_z
crossref_primary_10_1016_j_neubiorev_2016_01_007
crossref_primary_10_1016_j_neurobiolaging_2015_02_015
crossref_primary_10_1080_15622975_2020_1731925
crossref_primary_10_1007_s10517_024_06001_6
crossref_primary_10_3389_fphar_2024_1500527
crossref_primary_10_31857_S0044467723040081
crossref_primary_10_1016_j_neuropharm_2021_108720
crossref_primary_10_18632_aging_103116
crossref_primary_10_1021_acschemneuro_9b00220
crossref_primary_10_3389_fnagi_2020_588297
crossref_primary_10_1038_s41598_024_70261_5
crossref_primary_10_1038_s41386_018_0134_5
crossref_primary_10_1002_hipo_23130
crossref_primary_10_1007_s10522_018_9765_5
crossref_primary_10_1515_revneuro_2015_0062
crossref_primary_10_1016_j_phymed_2016_04_008
crossref_primary_10_1016_j_neurobiolaging_2017_08_025
crossref_primary_10_3389_fnsys_2018_00072
crossref_primary_10_1016_j_nlm_2019_03_007
crossref_primary_10_1016_j_jneumeth_2020_108760
crossref_primary_10_1038_s41598_018_28062_0
crossref_primary_10_2174_0929867325666180228170450
crossref_primary_10_3389_fpsyg_2022_998062
crossref_primary_10_1111_acel_12605
crossref_primary_10_1016_j_nlm_2018_12_001
crossref_primary_10_1007_s00213_025_06754_6
crossref_primary_10_1523_JNEUROSCI_2332_16_2016
crossref_primary_10_1111_jnc_14345
crossref_primary_10_1097_PR9_0000000000000952
crossref_primary_10_3390_molecules26206266
crossref_primary_10_1523_JNEUROSCI_0531_17_2017
crossref_primary_10_3389_fnsys_2018_00061
crossref_primary_10_1002_tox_24007
crossref_primary_10_1016_j_neuroscience_2016_02_014
crossref_primary_10_1016_j_neubiorev_2020_10_018
crossref_primary_10_3389_fnagi_2023_1274624
crossref_primary_10_1101_lm_042069_116
crossref_primary_10_3389_fnagi_2015_00193
crossref_primary_10_1016_j_jff_2019_103713
crossref_primary_10_1038_srep22096
crossref_primary_10_1016_j_bbih_2024_100798
crossref_primary_10_1007_s11055_023_01554_x
crossref_primary_10_1177_02698811231161579
crossref_primary_10_1002_hipo_23316
crossref_primary_10_1523_JNEUROSCI_1810_23_2024
crossref_primary_10_1016_j_neuro_2018_10_004
crossref_primary_10_1186_s13293_018_0214_6
crossref_primary_10_1523_ENEURO_0164_18_2018
crossref_primary_10_1523_ENEURO_0329_22_2023
crossref_primary_10_1523_ENEURO_0235_19_2019
crossref_primary_10_1016_j_molmed_2015_05_002
crossref_primary_10_1016_j_bpsc_2016_06_004
crossref_primary_10_1038_s41598_020_57626_2
crossref_primary_10_1093_ijnp_pyae048
crossref_primary_10_1016_j_physbeh_2020_113184
crossref_primary_10_1016_j_coph_2017_09_012
crossref_primary_10_18632_aging_103956
crossref_primary_10_1523_JNEUROSCI_2123_14_2015
crossref_primary_10_1016_j_neurobiolaging_2015_07_024
crossref_primary_10_1016_j_neuropharm_2022_109001
crossref_primary_10_1007_s00213_020_05684_9
crossref_primary_10_1016_j_celrep_2020_107729
crossref_primary_10_3389_fncir_2022_834173
crossref_primary_10_1007_s12678_021_00654_x
crossref_primary_10_1016_j_pnpbp_2014_11_001
crossref_primary_10_1038_s41598_017_15006_3
crossref_primary_10_1016_j_neurobiolaging_2021_04_027
crossref_primary_10_1523_ENEURO_0204_22_2023
crossref_primary_10_1016_j_neurobiolaging_2018_08_020
crossref_primary_10_1093_gerona_glu061
crossref_primary_10_3389_fnagi_2016_00025
crossref_primary_10_1038_s41598_021_00792_8
crossref_primary_10_1007_s00213_016_4321_y
crossref_primary_10_1016_j_brainresbull_2015_09_010
crossref_primary_10_1016_j_neurobiolaging_2016_05_015
crossref_primary_10_1016_j_neurobiolaging_2025_01_010
crossref_primary_10_1177_0269881120965931
crossref_primary_10_1038_npp_2016_178
crossref_primary_10_1016_j_arr_2023_101865
crossref_primary_10_1523_JNEUROSCI_3523_14_2015
crossref_primary_10_1093_gerona_glab301
crossref_primary_10_1080_1028415X_2018_1447296
crossref_primary_10_1038_s41598_024_51743_y
crossref_primary_10_3389_fphar_2020_581098
crossref_primary_10_1007_s12035_023_03516_3
crossref_primary_10_1007_s12603_015_0546_4
crossref_primary_10_1016_j_expneurol_2019_113075
crossref_primary_10_1016_j_pbb_2024_173900
crossref_primary_10_1523_JNEUROSCI_0135_17_2017
crossref_primary_10_1016_j_neuropharm_2020_108403
crossref_primary_10_3389_fnagi_2023_1306496
crossref_primary_10_1038_s41380_022_01632_5
crossref_primary_10_1155_2018_4160247
crossref_primary_10_3389_fphys_2023_1145973
crossref_primary_10_1016_j_neurobiolaging_2018_06_028
crossref_primary_10_1016_j_clinph_2023_04_010
crossref_primary_10_3389_fnhum_2019_00193
Cites_doi 10.3389/fnagi.2012.00019
10.1523/JNEUROSCI.3258-12.2013
10.1101/lm.031971.113
10.1093/cercor/bhn198
10.1017/S1355617798455073
10.1016/0896-6273(95)90304-6
10.1016/j.bbr.2003.09.028
10.1101/lm.45802
10.1016/j.neurobiolaging.2013.03.019
10.1016/j.bbr.2006.03.030
10.1523/JNEUROSCI.19-18-j0001.1999
10.1523/JNEUROSCI.1020-11.2011
10.1523/JNEUROSCI.20-22-08596.2000
10.1093/cercor/bht195
10.1111/j.1460-9568.1996.tb00727.x
10.1523/JNEUROSCI.15-11-07734.1995
10.1006/brcg.2001.1500
10.1037/0735-7044.119.2.420
10.1523/JNEUROSCI.23-35-11026.2003
10.1016/j.jneumeth.2008.01.033
10.1016/j.bcp.2004.07.030
10.1002/cne.22790
10.1007/BF02245056
10.1016/j.neuron.2006.04.014
10.1113/jphysiol.2007.134460
10.1152/jn.91161.2008
10.1016/j.biopsych.2010.09.038
10.1201/9781420005523-1
10.1073/pnas.93.24.13473
10.1016/j.neuroscience.2004.01.035
10.1016/0163-1047(93)90729-2
10.1046/j.1471-4159.2003.01681.x
10.1016/j.neuroscience.2009.08.055
10.1093/cercor/11.6.558
10.1002/cne.1335
10.1046/j.1460-9568.1998.00137.x
10.1523/JNEUROSCI.1766-04.2004
10.1037/0096-3445.132.4.566
10.1038/386239a0
10.1016/j.neurobiolaging.2011.11.011
10.1093/cercor/13.9.950
10.1523/JNEUROSCI.3364-04.2005
10.1016/j.bbr.2004.12.003
10.1038/25360
10.1016/j.neuropharm.2005.01.019
10.1016/0006-8993(94)91195-9
10.1523/JNEUROSCI.4178-05.2006
10.1038/nature10360
10.1152/jn.00240.2003
10.1016/S1054-3589(10)58010-4
10.1016/j.neuron.2012.12.032
10.1016/0306-4522(81)90053-1
10.1523/JNEUROSCI.1673-12.2012
10.1016/j.brainresrev.2004.03.003
10.1016/S1054-3589(10)58002-5
10.1038/25348
10.1097/00001756-200106130-00016
10.1016/S1054-3589(10)58008-6
10.1093/schbul/sbn070
10.1002/(SICI)1096-9861(19980504)394:2<252::AID-CNE9>3.0.CO;2-1
10.1038/nrn1648
10.1523/JNEUROSCI.3172-09.2010
10.1111/j.1460-9568.2010.07191.x
10.1038/25354
10.1038/nn.2751
ContentType Journal Article
Copyright Copyright © 2014 the authors 0270-6474/14/343457-10$15.00/0 2014
Copyright_xml – notice: Copyright © 2014 the authors 0270-6474/14/343457-10$15.00/0 2014
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7QG
7TK
5PM
DOI 10.1523/JNEUROSCI.5192-13.2014
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Animal Behavior Abstracts
Neurosciences Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Neurosciences Abstracts
Animal Behavior Abstracts
DatabaseTitleList
Neurosciences Abstracts
MEDLINE
MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1529-2401
EndPage 3466
ExternalDocumentID PMC3942567
24599447
10_1523_JNEUROSCI_5192_13_2014
Genre Research Support, U.S. Gov't, Non-P.H.S
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIA NIH HHS
  grantid: AG029421
– fundername: NIA NIH HHS
  grantid: R01 AG029421
GroupedDBID ---
-DZ
-~X
.55
18M
2WC
34G
39C
53G
5GY
5RE
5VS
AAFWJ
AAJMC
AAYXX
ABBAR
ABIVO
ACGUR
ACNCT
ADBBV
ADCOW
ADHGD
AENEX
AETEA
AFCFT
AFOSN
AFSQR
AHWXS
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
CITATION
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
GX1
H13
HYE
H~9
KQ8
L7B
OK1
P0W
P2P
QZG
R.V
RHI
RPM
TFN
TR2
W8F
WH7
WOQ
X7M
XJT
YBU
YHG
YKV
YNH
YSK
AFHIN
AIZTS
CGR
CUY
CVF
ECM
EIF
NPM
RHF
7X8
7QG
7TK
5PM
ID FETCH-LOGICAL-c447t-7c2bcffc334345368bee3f9f063bcc360d1d8ebb2b91aa0c0afb3d3758278113
ISSN 0270-6474
1529-2401
IngestDate Thu Aug 21 18:11:19 EDT 2025
Thu Aug 21 01:22:24 EDT 2025
Fri Jul 11 02:49:02 EDT 2025
Wed Feb 19 02:08:25 EST 2025
Thu Apr 24 23:04:20 EDT 2025
Tue Jul 01 03:47:10 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords inhibition
GABA(B) receptor
aging
CGP55845
prefrontal cortex
executive function
Language English
License https://creativecommons.org/licenses/by-nc-sa/4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c447t-7c2bcffc334345368bee3f9f063bcc360d1d8ebb2b91aa0c0afb3d3758278113
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author contributions: B.S. and J.L.B. designed research; C.B., B.S.B., and R.J.G. performed research; J.A.M., C.J.F., and B.S. contributed unpublished reagents/analytic tools; C.B., B.S., and J.L.B. analyzed data; C.B. and J.L.B. wrote the paper.
OpenAccessLink https://www.jneurosci.org/content/jneuro/34/10/3457.full.pdf
PMID 24599447
PQID 1505255961
PQPubID 23479
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3942567
proquest_miscellaneous_1827907929
proquest_miscellaneous_1505255961
pubmed_primary_24599447
crossref_primary_10_1523_JNEUROSCI_5192_13_2014
crossref_citationtrail_10_1523_JNEUROSCI_5192_13_2014
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-03-05
PublicationDateYYYYMMDD 2014-03-05
PublicationDate_xml – month: 03
  year: 2014
  text: 2014-03-05
  day: 05
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of neuroscience
PublicationTitleAlternate J Neurosci
PublicationYear 2014
Publisher Society for Neuroscience
Publisher_xml – name: Society for Neuroscience
References 2023041304094166000_34.10.3457.51
2023041304094166000_34.10.3457.50
2023041304094166000_34.10.3457.13
2023041304094166000_34.10.3457.57
2023041304094166000_34.10.3457.12
2023041304094166000_34.10.3457.15
2023041304094166000_34.10.3457.59
2023041304094166000_34.10.3457.14
2023041304094166000_34.10.3457.58
2023041304094166000_34.10.3457.53
2023041304094166000_34.10.3457.52
2023041304094166000_34.10.3457.11
2023041304094166000_34.10.3457.55
2023041304094166000_34.10.3457.10
2023041304094166000_34.10.3457.54
2023041304094166000_34.10.3457.2
2023041304094166000_34.10.3457.1
2023041304094166000_34.10.3457.17
2023041304094166000_34.10.3457.19
2023041304094166000_34.10.3457.18
2023041304094166000_34.10.3457.9
2023041304094166000_34.10.3457.8
2023041304094166000_34.10.3457.7
Kulik (2023041304094166000_34.10.3457.34) 2003; 23
2023041304094166000_34.10.3457.6
2023041304094166000_34.10.3457.5
2023041304094166000_34.10.3457.4
2023041304094166000_34.10.3457.3
2023041304094166000_34.10.3457.46
2023041304094166000_34.10.3457.45
2023041304094166000_34.10.3457.48
2023041304094166000_34.10.3457.47
2023041304094166000_34.10.3457.42
Minelli (2023041304094166000_34.10.3457.40) 1995; 15
2023041304094166000_34.10.3457.41
2023041304094166000_34.10.3457.44
2023041304094166000_34.10.3457.43
2023041304094166000_34.10.3457.49
2023041304094166000_34.10.3457.35
2023041304094166000_34.10.3457.37
2023041304094166000_34.10.3457.36
2023041304094166000_34.10.3457.31
Wong (2023041304094166000_34.10.3457.65) 2000; 20
2023041304094166000_34.10.3457.30
2023041304094166000_34.10.3457.33
2023041304094166000_34.10.3457.32
2023041304094166000_34.10.3457.39
2023041304094166000_34.10.3457.38
2023041304094166000_34.10.3457.60
2023041304094166000_34.10.3457.62
2023041304094166000_34.10.3457.61
2023041304094166000_34.10.3457.24
2023041304094166000_34.10.3457.23
2023041304094166000_34.10.3457.67
2023041304094166000_34.10.3457.26
2023041304094166000_34.10.3457.25
2023041304094166000_34.10.3457.20
2023041304094166000_34.10.3457.64
2023041304094166000_34.10.3457.63
Froestl (2023041304094166000_34.10.3457.16) 1996; 8
2023041304094166000_34.10.3457.22
2023041304094166000_34.10.3457.66
2023041304094166000_34.10.3457.21
2023041304094166000_34.10.3457.28
2023041304094166000_34.10.3457.27
Taylor (2023041304094166000_34.10.3457.56) 1999; 19
2023041304094166000_34.10.3457.29
References_xml – ident: 2023041304094166000_34.10.3457.6
  doi: 10.3389/fnagi.2012.00019
– ident: 2023041304094166000_34.10.3457.7
  doi: 10.1523/JNEUROSCI.3258-12.2013
– ident: 2023041304094166000_34.10.3457.63
  doi: 10.1101/lm.031971.113
– ident: 2023041304094166000_34.10.3457.67
  doi: 10.1093/cercor/bhn198
– ident: 2023041304094166000_34.10.3457.49
  doi: 10.1017/S1355617798455073
– ident: 2023041304094166000_34.10.3457.20
  doi: 10.1016/0896-6273(95)90304-6
– ident: 2023041304094166000_34.10.3457.44
– ident: 2023041304094166000_34.10.3457.58
  doi: 10.1016/j.bbr.2003.09.028
– ident: 2023041304094166000_34.10.3457.48
  doi: 10.1101/lm.45802
– ident: 2023041304094166000_34.10.3457.4
  doi: 10.1016/j.neurobiolaging.2013.03.019
– volume: 8
  start-page: 127
  year: 1996
  ident: 2023041304094166000_34.10.3457.16
  article-title: Potent, orally active GABAB receptor antagonists
  publication-title: Pharmacol Rev Commun
– ident: 2023041304094166000_34.10.3457.52
  doi: 10.1016/j.bbr.2006.03.030
– volume: 19
  start-page: RC23
  year: 1999
  ident: 2023041304094166000_34.10.3457.56
  article-title: Activation of cAMP-dependent protein kinase A in prefrontal cortex impairs working memory performance
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.19-18-j0001.1999
– ident: 2023041304094166000_34.10.3457.54
  doi: 10.1523/JNEUROSCI.1020-11.2011
– volume: 20
  start-page: 8596
  year: 2000
  ident: 2023041304094166000_34.10.3457.65
  article-title: Loss of presynaptic and postsynaptic structures is accompanied by compensatory increase in action potential-dependent synaptic input to layer V neocortical pyramidal neurons in aged rats
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.20-22-08596.2000
– ident: 2023041304094166000_34.10.3457.2
  doi: 10.1093/cercor/bht195
– ident: 2023041304094166000_34.10.3457.10
  doi: 10.1111/j.1460-9568.1996.tb00727.x
– volume: 15
  start-page: 7734
  year: 1995
  ident: 2023041304094166000_34.10.3457.40
  article-title: GAT-1, a high-affinity GABA plasma membrane transporter, is localized to neurons and astroglia in the cerebral cortex
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.15-11-07734.1995
– ident: 2023041304094166000_34.10.3457.57
  doi: 10.1006/brcg.2001.1500
– ident: 2023041304094166000_34.10.3457.53
  doi: 10.1037/0735-7044.119.2.420
– volume: 23
  start-page: 11026
  year: 2003
  ident: 2023041304094166000_34.10.3457.34
  article-title: Subcellular localization of metabotropic GABA(B) receptor subunits GABA(B1a/b) and GABA(B2) in the rat hippocampus
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.23-35-11026.2003
– ident: 2023041304094166000_34.10.3457.1
  doi: 10.1016/j.jneumeth.2008.01.033
– ident: 2023041304094166000_34.10.3457.17
  doi: 10.1016/j.bcp.2004.07.030
– ident: 2023041304094166000_34.10.3457.55
  doi: 10.1002/cne.22790
– ident: 2023041304094166000_34.10.3457.3
  doi: 10.1007/BF02245056
– ident: 2023041304094166000_34.10.3457.60
  doi: 10.1016/j.neuron.2006.04.014
– ident: 2023041304094166000_34.10.3457.19
  doi: 10.1113/jphysiol.2007.134460
– ident: 2023041304094166000_34.10.3457.25
  doi: 10.1152/jn.91161.2008
– ident: 2023041304094166000_34.10.3457.13
  doi: 10.1016/j.biopsych.2010.09.038
– ident: 2023041304094166000_34.10.3457.18
  doi: 10.1201/9781420005523-1
– ident: 2023041304094166000_34.10.3457.21
  doi: 10.1073/pnas.93.24.13473
– ident: 2023041304094166000_34.10.3457.38
  doi: 10.1016/j.neuroscience.2004.01.035
– ident: 2023041304094166000_34.10.3457.41
  doi: 10.1016/0163-1047(93)90729-2
– ident: 2023041304094166000_34.10.3457.59
  doi: 10.1046/j.1471-4159.2003.01681.x
– ident: 2023041304094166000_34.10.3457.36
  doi: 10.1016/j.neuroscience.2009.08.055
– ident: 2023041304094166000_34.10.3457.27
  doi: 10.1093/cercor/11.6.558
– ident: 2023041304094166000_34.10.3457.46
  doi: 10.1002/cne.1335
– ident: 2023041304094166000_34.10.3457.11
  doi: 10.1046/j.1460-9568.1998.00137.x
– ident: 2023041304094166000_34.10.3457.32
  doi: 10.1523/JNEUROSCI.1766-04.2004
– ident: 2023041304094166000_34.10.3457.50
  doi: 10.1037/0096-3445.132.4.566
– ident: 2023041304094166000_34.10.3457.30
  doi: 10.1038/386239a0
– ident: 2023041304094166000_34.10.3457.39
  doi: 10.1016/j.neurobiolaging.2011.11.011
– ident: 2023041304094166000_34.10.3457.12
  doi: 10.1093/cercor/13.9.950
– ident: 2023041304094166000_34.10.3457.8
  doi: 10.1523/JNEUROSCI.3364-04.2005
– ident: 2023041304094166000_34.10.3457.42
  doi: 10.1016/j.bbr.2004.12.003
– ident: 2023041304094166000_34.10.3457.31
  doi: 10.1038/25360
– ident: 2023041304094166000_34.10.3457.26
  doi: 10.1016/j.neuropharm.2005.01.019
– ident: 2023041304094166000_34.10.3457.47
  doi: 10.1016/0006-8993(94)91195-9
– ident: 2023041304094166000_34.10.3457.35
  doi: 10.1523/JNEUROSCI.4178-05.2006
– ident: 2023041304094166000_34.10.3457.66
  doi: 10.1038/nature10360
– ident: 2023041304094166000_34.10.3457.28
  doi: 10.1152/jn.00240.2003
– ident: 2023041304094166000_34.10.3457.45
  doi: 10.1016/S1054-3589(10)58010-4
– ident: 2023041304094166000_34.10.3457.61
  doi: 10.1016/j.neuron.2012.12.032
– ident: 2023041304094166000_34.10.3457.22
  doi: 10.1016/0306-4522(81)90053-1
– ident: 2023041304094166000_34.10.3457.33
  doi: 10.1523/JNEUROSCI.1673-12.2012
– ident: 2023041304094166000_34.10.3457.9
  doi: 10.1016/j.brainresrev.2004.03.003
– ident: 2023041304094166000_34.10.3457.15
  doi: 10.1016/S1054-3589(10)58002-5
– ident: 2023041304094166000_34.10.3457.29
  doi: 10.1038/25348
– ident: 2023041304094166000_34.10.3457.14
  doi: 10.1097/00001756-200106130-00016
– ident: 2023041304094166000_34.10.3457.23
  doi: 10.1016/S1054-3589(10)58008-6
– ident: 2023041304094166000_34.10.3457.24
  doi: 10.1093/schbul/sbn070
– ident: 2023041304094166000_34.10.3457.51
  doi: 10.1002/(SICI)1096-9861(19980504)394:2<252::AID-CNE9>3.0.CO;2-1
– ident: 2023041304094166000_34.10.3457.37
  doi: 10.1038/nrn1648
– ident: 2023041304094166000_34.10.3457.5
  doi: 10.1523/JNEUROSCI.3172-09.2010
– ident: 2023041304094166000_34.10.3457.62
  doi: 10.1111/j.1460-9568.2010.07191.x
– ident: 2023041304094166000_34.10.3457.64
  doi: 10.1038/25354
– ident: 2023041304094166000_34.10.3457.43
  doi: 10.1038/nn.2751
SSID ssj0007017
Score 2.4712555
Snippet Working memory functions supported by the prefrontal cortex decline in normal aging. Disruption of corticolimbic GABAergic inhibitory circuits can impair...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 3457
SubjectTerms Aging - drug effects
Aging - physiology
Animals
Dose-Response Relationship, Drug
GABA-B Receptor Antagonists - pharmacology
Male
Memory Disorders - metabolism
Memory, Short-Term - drug effects
Memory, Short-Term - physiology
Prefrontal Cortex - drug effects
Prefrontal Cortex - metabolism
Prefrontal Cortex - physiopathology
Rats
Rats, Inbred F344
Reaction Time - drug effects
Reaction Time - physiology
Receptors, GABA-B - metabolism
Receptors, GABA-B - physiology
Title Prefrontal Cortical GABAergic Dysfunction Contributes to Age-Related Working Memory Impairment
URI https://www.ncbi.nlm.nih.gov/pubmed/24599447
https://www.proquest.com/docview/1505255961
https://www.proquest.com/docview/1827907929
https://pubmed.ncbi.nlm.nih.gov/PMC3942567
Volume 34
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9NAFB6FcuGCgLKETYOEuERObc94OzphKUWJWhqknrA8iyGodarUOYTfxw_jzRJ70lYsvViR7Yk9-b68edu8h9DrOCGci1h4QmSpRwnlXinSzBM8Fn7AlERUEd3JNN7_Qg9OopNe75eTtbRq2JD_vHZfyU1QhXOAq9ol-x_Itl8KJ-Az4AtHQBiO_4TxISxvqgCBdgAsjVf6Qz7K5RLk2eDt-kKtWhpgVYRKt7YyFR3yb9LTaXCgblp3-WCicm7XqlxwOV-2-TA_OjY5uqtTBbOLypcq6D4KVvLUpO6NtfyoO4tfms1jo-HgGKbdnp_wo1VpXdE6HjHIh21a0FzV4NILxee12mk1dN0UAdV5WlHnpnRyUKeX39GIuzABQ5aanj1DacVxqOM_gSuvrfPT8tJ3pC-hpti1XckJNQ1drqwSka5WcTBVyZLH449D0GJDLyAq0Y-6AwDt8zPNnZBGWUZp0q2abS7j4WRMMpB8cXIL3Q7BWFHS9tNRV7M-8XXf53Z-dp86vMTe9a-gClTb521rS1dMoMuZvI5qNLuH7lpe4NwQ9D7qyfoB2s3rslmcrfEbrLOMdfhmF33tOIs3nMUtZ7HDWexwFjcL7HAWW85iw1nccfYhmr1_Nxvve7bHh8dheo2X8JDxquKEgJyISJwyKUmVVaA5M85J7ItApJKxkGVBWfrcLytGBAErN1R7pMkjtFMvavkEYcYCkEa0kjzltITFMyaiBPM8YLKKRUr7KNr8lAW39e9VG5bTQtnBgEbRolEoNIqAFAqNPtprx52bCjB_HfFqg1QBwlpF4MpaLlYXMEi1jYyyOPjDPTCzzE_AbOmjxwbd9rkbWvRRsoV7e4MqFr99pZ5_10XjLUef3njkM3Sn-18_RzvNciVfgELesJea778BEhfh6Q
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prefrontal+Cortical+GABAergic+Dysfunction+Contributes+to+Age-Related+Working+Memory+Impairment&rft.jtitle=The+Journal+of+neuroscience&rft.au=Ba%C3%B1uelos%2C+Cristina&rft.au=Beas%2C+B.+Sofia&rft.au=McQuail%2C+Joseph+A.&rft.au=Gilbert%2C+Ryan+J.&rft.date=2014-03-05&rft.pub=Society+for+Neuroscience&rft.issn=0270-6474&rft.eissn=1529-2401&rft.volume=34&rft.issue=10&rft.spage=3457&rft.epage=3466&rft_id=info:doi/10.1523%2FJNEUROSCI.5192-13.2014&rft_id=info%3Apmid%2F24599447&rft.externalDocID=PMC3942567
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-6474&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-6474&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-6474&client=summon